MLTX
MoonLake Immunotherapeutics
-0.12 (-0.92%)12.35USD413K成交股數1.1B市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 50.2M | 54.5M | 56.0M | 60.6M | 49.8M | 36.5M | 35.7M | 23.7M | 13.0M | 8.1M | 7.6M | 8.7M |
| 銷售管理費用 | 11.4M | 15.5M | 9.2M | 10.8M | 10.9M | 11.0M | 7.4M | 6.9M | 6.8M | 6.9M | 5.4M | 4.5M |
| 營業利益 | −61.7M+2% | −70.0M+47% | −65.2M+51% | −71.4M+134% | −60.7M+206% | −47.5M+216% | −43.1M+232% | −30.6M+132% | −19.8M | −15.0M | −13.0M | −13.2M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −61.8M+12% | −69.7M+75% | −62.4M+76% | −69.7M+187% | −55.2M+304% | −39.9M+437% | −35.4M+275% | −24.3M+139% | −13.7M | −7.4M | −9.4M | −10.1M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.84-3% | -0.98+56% | -0.93+66% | -1.10+182% | -0.87+295% | -0.63+600% | -0.56+211% | -0.39+70% | -0.22 | -0.09 | -0.18 | -0.23 |
| 稀釋股數 | 73.9M | 71.3M | 64.5M | 63.4M | 63.3M | 63.2M | 62.9M | 62.9M | 62.6M | 49.1M | 53.5M | 43.7M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 478M | 298M | 335M | 351M | 307M | 272M | 376M | 343M | 458M | 451M | 318M | 502M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 574M | 400M | 424M | 414M | 460M | 511M | 518M | 545M | 564M | 527M | 500M | 507M |
| 有息負債 | 99.5M | 99.0M | 74.1M | 73.7M | 73.4M | 73.0M | – | – | – | – | – | – |
| 總負債 | 146M | 146M | 120M | 123M | 102M | 98.7M | 22.7M | 14.8M | 11.7M | 13.0M | 10.6M | 7.5M |
| 股東權益 | 428M | 254M | 304M | 289M | 354M | 408M | 488M | 521M | 543M | 496M | 425M | 490M |
| 負債比 | 25.4% | 36.6% | 28.3% | 29.7% | 22.2% | 19.3% | 4.4% | 2.7% | 2.1% | 2.5% | 2.1% | 1.5% |
| 淨現金(現金 − 有息負債) | 378M | 199M | 260M | 277M | 233M | 199M | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −66.3M+74% | – | – | – | −38.1M | – | – | −14.9M | – | – | – |
| 資本支出 | – | 0.00 | – | – | – | 35K | – | – | 212K | – | – | – |
| 自由現金流 | – | −66.3M+74% | – | – | – | −38.2M | – | – | −15.2M | – | – | – |
| 折舊攤銷 | – | 845K | – | – | – | 378K | – | – | 328K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | 50.00 | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −227M | –% | -3.53 | −196M |
| FY2024 | – | – | −119M | –% | -1.89 | −117M |
| FY2023 | – | – | −36.0M | –% | -0.73 | −43.1M |
| FY2022 | – | – | −50.0M | –% | -1.70 | −55.9M |
| FY2021 | – | – | −4.5M | –% | -0.31 | – |